Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Head and Neck Cancer

Treatments: Behavioral: Assessments

Study type: Observational

Funder types: Other

Identifiers

NCT02571673

15-245

Details and patient eligibility

About

This study is being done to understand how survivors of head and neck cancer think they can make HN-STAR (the Survivor Self-Assessment, the survivorship clinic experience, and the Survivorship Care Plan the best it can be. Once the investigators have your input and input from other survivors, they can make changes to HN-STAR, so that they can test this tool in a larger study. The larger study will tell them whether using HN-STAR improves the care of head and neck cancer survivors.

Enrollment: 65 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Aim 1: Part 1

• Have completed treatment for head and neck cancer at least 1 year prior to survivorship visit and have no evidence of disease
• Have a primary care provider
• Be able to provide informed consent
• Be able to speak and read English
• Be at least 18 years old

Aim 1: Part 2

• Have completed treatment for head and neck cancer at least 1 year prior to survivorship visit and have no evidence of disease
• Have a primary care provider
• Be able to provide informed consent
• Be able to speak and read English
• Be at least 18 years old

Exclusion criteria

Aim 1: Parts 1 and 2 is the same

• Patients or providers who cannot speak or read English
• Patients with cognitive, visual, or motor impairment such that they cannot complete the Survivor Self-Assessment as assessed by the research team.

Trial design

65 participants in 1 patient group

Survivors of head and neck cancer

Description:

Data collection will take place in two parts. Aim 1: Part 1 will enroll 10 patients at MSK to participate in component pilot testing and usability testing of HN-STAR and the associated surveys. We will also elicit feedback from the NP. After incorporating any changes to HN-STAR or the surveys based on findings from Aim 1: Part 1, Aim 1: Part 2 will enroll 30 additional patients from MSK and 15 from HH to provide feedback on usability. We will also survey each patient's PCP in Aim 1: Part 2.

Treatment:

Behavioral: Assessments